Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law FirmPR Newswire·4 hours agoKYMR+0.10%
Everest Medicines CFO to join Morgan Stanley Biotech Without Borders fireside chatPUBT·2 hours agoMS-1.10%01952+2.19%
FDA panel approves expanded use of peptides in compounding pharmacies, raising concerns about prescription surge in billion-dollar industry.Unusual Whales·2 days ago, 05:24 PMIXJ+0.88%BBH+0.78%
Thermo Fisher Rated Buy on Broad-Based Recovery, Conservative Guidance, and Attractive Valuation Versus PeersTip Ranks·Jul 24 at 02:15 AMTMO-1.06%
12:26 ETNASDAQ: ERAS CLASS ACTION NOTICE: Berger Montague Encourages Erasca, Inc. (NASDAQ: ERAS) Investors to Inquire About a Securities Fraud Class Actionprnewswire·Jul 22 at 11:26 AMERAS+0.21%
Fed Chair Kevin Warsh faces a committee where 9 of 19 members are signaling higher interest rates this yearMSN·9 hours ago
He has a bigger fish to fry: Why one analyst thinks Trump might let Kevin Warsh hike rates this monthMSN·3 hours ago
16:26 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSSprnewswire·Jul 21 at 03:28 PMERAS+0.21%RVMD-0.91%
From confidence to capital: Positioning biotech for the next growth cyclebiopharmadive·1 hour agoLABU+1.56%LABD-1.82%
15:31 ETErasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuitprnewswire·2 days ago, 02:31 PMERAS+0.21%
